You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

OptimICE-RD

Showing 1 - 25 of 294
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer Trial in United States (Sacituzumab govitecan-hziy (SG), Pembrolizumab, Capecitabine)

Recruiting
  • Triple Negative Breast Cancer
  • Sacituzumab govitecan-hziy (SG)
  • +2 more
  • Glendale, Arizona
  • +7 more
Jan 26, 2023

Autoimmune Diseases Trial in Beijing (, mycophenolate mofetil)

Not yet recruiting
  • Autoimmune Diseases
  • placebo
  • mycophenolate mofetil
  • Beijing, China
    Peking Union Medical College Hospital
Jul 26, 2023

IgG4-related Disease Trial (Sirolimus)

Not yet recruiting
  • IgG4-related Disease
  • (no location specified)
Feb 25, 2023

Anterior Cruciate Ligament Injuries Trial in China (Reverse drilling technique, Traditional extraction drilling)

Not yet recruiting
  • Anterior Cruciate Ligament Injuries
  • Reverse drilling technique
  • Traditional extraction drilling
  • Huzhou, Zhejiang, China
  • +5 more
Aug 9, 2023

Fabry Disease Who Received Lentiviral Gene Therapy in Study

Enrolling by invitation
  • Fabry Disease
  • Safety and Efficacy Assessments
  • Melbourne, Parkville VIC, Australia
  • +2 more
Oct 5, 2022

Newly Diagnosed Multiple Myeloma Trial in Austria (Isatuximab-Irfc 20 MG/ML [Sarclisa], Lenalidomide, Dexamethasone Oral)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • Isatuximab-Irfc 20 MG/ML [Sarclisa]
  • +2 more
  • Innsbruck, Tirol, Austria
  • +15 more
Aug 24, 2022

Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

Not yet recruiting
  • Acute Myeloid Leukemia
  • High-Risk and Very High-Risk Myelodysplastic Syndromes
  • (no location specified)
Jul 25, 2023

IgG4 Related Disease Trial in United States (Obexelimab, Placebo)

Recruiting
  • IgG4 Related Disease
  • Walnut Creek, California
  • +3 more
Jan 27, 2023

IgG4 Related Disease, IgG4-RD Trial in Atlanta, Boston, Rochester (elotuzumab, for elotuzumab, methylprednisolone)

Recruiting
  • IgG4 Related Disease
  • IgG4-RD
  • Atlanta, Georgia
  • +2 more
Jul 13, 2022

IgG4 Related Disease Trial in Worldwide (Inebilizumab, Placebo)

Recruiting
  • IgG4 Related Disease
  • Palo Alto, California
  • +81 more
Oct 19, 2022

COVID-19 Trial in Huber Heights (RD-X19, Sham)

Recruiting
  • COVID-19
  • RD-X19
  • Sham
  • Huber Heights, Ohio
    Site 303
Apr 14, 2023

B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • (no location specified)
Oct 10, 2023

Tumors Trial in Japan, Korea, Republic of, Taiwan (BI 754091, BI 754111)

Active, not recruiting
  • Neoplasms
  • BI 754091
  • BI 754111
  • Chiba, Kashiwa, Japan
  • +12 more
Aug 9, 2022

Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)

Active, not recruiting
  • Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
  • Yamagata, Japan
    Yamagata University Hospital
Feb 21, 2022

Multiple Myeloma, Myeloma Trial in Poitiers (Isatuximab, Lenalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Myeloma
  • Poitiers, France
    CHU Poitiers
Sep 5, 2022

Intravitreous CytokinE Level in pAtient With retiNal Detachment

Completed
  • Retinal Detachment
  • Vitrectomy
  • Vandœuvre-lès-Nancy, France
    Brabois Hospital
Jul 18, 2022

Autoimmune Diseases Trial in Beijing (Diprospan plus iguratimod, Diprospan plus leflunomide, Prednisone plus leflunomide)

Recruiting
  • Autoimmune Diseases
  • Diprospan plus iguratimod
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Mar 16, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +145 more
Jan 17, 2023

Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

Not yet recruiting
  • Mature B-Cell Neoplasm
  • +25 more
  • (no location specified)
Sep 14, 2022

Advanced or Metastatic Solid Tumors Trial in Australia, Korea, Republic of (HM97662)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • Adelaide, Australia
  • +7 more
Oct 24, 2022

Autoimmune Diseases Trial in Beijing (Prednisone and Mycophenolate Mofetil, Mycophenolate Mofetil, Leflunomide)

Recruiting
  • Autoimmune Diseases
  • Prednisone and Mycophenolate Mofetil
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Mar 16, 2023

Head and Neck Squamous Cell Carcinoma, Melanoma Excluding Uveal Melanoma, NSCLC, Squamous or Non-squamous Trial in Denver,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +8 more
  • XmAb®808
  • Keytruda® (pembrolizumab)
  • Denver, Colorado
  • +2 more
Jan 19, 2023

Gastric or Gastroesophageal Cancer Trial in Kawasaki-shi, Chuo-ku (FPA144)

Completed
  • Gastric or Gastroesophageal Cancer
  • Kawasaki-shi, Kanagawa, Japan
  • +1 more
Jun 13, 2023

Deep Learning-based Classification and Prediction of Radiation

Recruiting
  • Radiation Dermatitis
  • Head and Neck Cancer
    • Shenzhen, Guangdong, China
    • +1 more
    Oct 31, 2022

    Type 1 Gaucher Disease Who Previously Received AVR-RD-02

    Enrolling by invitation
    • Type 1 Gaucher Disease
    • Safety and efficacy assessments
    • Calgary, Calgary Alberta, Canada
      University of Calgary
    Oct 29, 2021